Safety signal detection and evaluation in clinical development programs: A case study of tofacitinib

E-ISSN： 2052-1707|6|1|prp2.371-prp2.371

ISSN： 2052-1707

Source： Pharmacology Research & Perspectives, Vol.6, Iss.1, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Bayesian Group Sequential Approach to Safety Signal Detection

By Chen Wenfeng Zhao Naiqing Qin Guoyou Chen Jie

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 213-230

Taylor & Francis Ltd

Access to resources Recommend Favorite

Signal detection methodologies to support effective safety management

By van Manen Robbert P Fram David DuMouchel William

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 451-464

Informa Healthcare

Access to resources Recommend Favorite

Tofacitinib

Drugs in R&D, Vol. 10, Iss. 4, 2010-11 ,pp. : 271-284

Adis International

Access to resources Recommend Favorite

A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis

By Bannwarth Bernard Kostine Marie Poursac Nicolas

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 753-761

Informa Healthcare

Access to resources Recommend Favorite

Data Mining for Signal Detection of Adverse Event Safety Data

By Chen Hung-Chia Tsong Yi Chen James J.

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 146-160

Taylor & Francis Ltd

Access to resources Recommend Favorite